Generic Drug Firm Asks Supreme Court To Hear Dispute Over Induced Infringement
WASHINGTON, D.C. — In a Sept. 7 reply brief supporting its petition for certiorari, generic drug maker Teva Pharmaceuticals USA Inc. tells the U.S. Supreme Court that the Federal Circuit U.S....To view the full article, register now.
Already a subscriber? Click here to view full article